Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Opioid Manag. 2021 May-Jun;17(3):215–225. doi: 10.5055/jom.2021.0632

Table 1.

Demographic characteristics by opioid use between one month before conception and the end of pregnancy, National Birth Defects Prevention Study (controls), 1997-2011

Total
(n = 10,491)
No opioid use
(n = 10,021)
Opioid use duration
Any (n = 470) p ≤7 days
(n = 234)
p >7 days
(n = 236)
p
Median opioid use duration (day) NA NA 8 (2-45) NA 2 (1-4) NA 45 (21-153) NA
Gestational age (week) 38.7 ± 1.9 38.7 ± 1.9 38.5 ± 1.9 0.013 38.6 ± 1.6 0.679 38.3 ± 2.2 0.005
 <37 (preterm) 838 (8.0) 787 (7.9) 51 (10.9) 0.019 24 (10.3) 0.178 27 (11.4) 0.044
 ≥37 (term) 9,653 (92.0) 9,234 (92.1) 419 (89.1) 210 (897) 209 (88.6)
Birthweight among term births (g) 3430.9 ± 460.1 3431.4 ± 459.6 3420.9 ± 469.6 0.647 3459.6 ± 464.7 0.380 3382.0 ± 472.5 0.125
 <2500 (low) 172 (1.8) 167 (1.8) 5 (1.2) 0.352 1 (0.5) 0.189 4 (1.9) 0.792
 ≥2500 (normal) 9,481 (98.2) 9,067 (98.2) 414 (98.8) 209 (99.5) 205 (98.1)
Maternal age at delivery (years) 27.7 ± 6.1 27.8 ± 6.1 27.3 ± 5.5 0.079 27.2 ± 57 0.141 27.4 ± 5.4 0.354
 <20 1,034 (9.9) 1,003 (10.0) 31 (6.6) 0.0002 15 (6.4) 0.035 16 (6.8) 0.003
 20-34 7,977 (76.0) 7,582 (75.7) 395 (84.0) 194 (82.9) 201 (85.2)
 ≥35 1,480 (14.1) 1,436 (14.3) 44 (9.4) 25 (10.7) 19 (8.0)
Maternal race/ethnicity <0.0001 <0.0001 <0.0001
 Non-Hispanic White 6,313 (60.2) 5,954 (59.4) 359 (76.4) 180 (76.9) 179 (75.9)
 Non-Hispanic Black 1,199 (11.4) 1,151 (11.5) 48 (10.2) 21 (9.0) 27 (11.4)
 Hispanic 2,270 (21.6) 2,228 (22.2) 42 (8.9) 21 (9.0) 21 (8.9)
 Other/mixed 709 (6.8) 688 (6.9) 21 (4.5) 12 (5.1) 9 (3.8)
Maternal education <0.0001 0.0006 0.018
 <High school 1,527 (14.6) 1,489 (14.9) 38 (8.1) 16 (6.8) 22 (9.3)
 ≥High school 8,964 (85.4) 8,532 (85.1) 432 (91.9) 218 (93.2) 214 (90.7)
Maternal pre-pregnancy BMI (kg/m2) 0.040 0.112 0.175
 Not obese (<30) 8,568 (81.7) 8,201 (81.8) 367 (78.1) 182 (77.8) 185 (78.4)
 Obese (≥30) 1,923 (18.3) 1,820 (18.2) 103 (21.9) 52 (22.2) 51 (21.6)
Maternal smoking§ <0.0001 <0.0001 <0.0001
 Yes 1,945 (18.5) 1,766 (17.6) 179 (38.1) 79 (33.8) 100 (42.4)
 No 8,546 (81.5) 8,255 (82.4) 291 (61.9) 155 (66.2) 136 (57.6)
Maternal alcohol consumption§ 0.020 0.321 0.019
 Yes 4,039 (38.5) 3,834 (38.3) 205 (43.6) 97 (41.5) 108 (45.8)
 No 6,452 (61.5) 6,187 (61.7) 265 (56.4) 137 (58.5) 128 (54.2)
Maternal residence <0.0001 0.005 <0.0001
 Arkansas 1,351 (12.9) 1,251 (12.5) 100 (21.3) 43 (18.4) 57 (24.2)
 California 1,087 (10.4) 1,047 (10.4) 40 (8.5) 22 (9.4) 18 (7.6)
 Georgia 1,121 (10.7) 1,080 (10.8) 41 (8.7) 23 (9.8) 18 (7.6)
 Iowa 1,207 (11.5) 1,140 (11.4) 67 (14.2) 40 (17.1) 27 (11.4)
 Massachusetts 1,295 (12.3) 1,236 (12.3) 59 (12.5) 30 (12.8) 29 (12.3)
 New Jersey 523 (5.0) 510 (5.1) 13 (2.8) 7 (3.0) 6 (2.6)
 New York 914 (8.7) 884 (8.8) 30 (6.4) 12 (5.1) 18 (7.6)
 North Carolina 884 (8.4) 847 (8.5) 37 (7.9) 20 (8.6) 17 (7.2)
 Texas 1,157 (11.0) 1,121 (11.2) 36 (7.7) 15 (6.4) 21 (8.9)
 Utah 952 (9.1) 905 (9.0) 47 (10.0) 22 (9.4) 25 (10.6)
Estimated date of delivery year 0.221 0.372 0.378
 1997-2001 3,128 (29.8) 3,004 (30.0) 124 (26.4) 63 (26.9) 61 (25.9)
 2002-2006 3,822 (36.4) 3,638 (36.3) 184 (39.1) 95 (40.6) 89 (37.7)
 2007-2011 3,541 (33.8) 3,379 (33.7) 162 (34.5) 76 (32.5) 86 (36.4)

NA, not applicable; BMI, body mass index.

Data are median (25th percentile-75th percentile), mean ± standard deviation, or n (percent).

Compared to no opioid use, p values were calculated using two-sample t-tests for continuous variables and chi-square and Fisher’s exact tests for categorical variables.

Total term births: n = 9,653; No opioid use term births: n = 9,234; Any opioid use term births: n = 414; ≤ 7 days opioid use term births: n = 210; > 7 days of opioid use term births: n = 209.

§

Reported use between one month before conception and the third month of pregnancy.